Skip to content

Internet Mindfulness Meditation Intervention (IMMI) Program with iMINDr Application Support for Older Adults with Depression Symptoms: A Feasibility Study

Lutvija Hrnjic, Nina Fry, Helané Wahbeh

OBM Integrative and Complementary Medicine October 14, 2021 DOI: 10.21926/obm.icm.2104034 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pre-post intervention study Peer reviewed
Sample size 38
Population Older adults with depressive symptoms recruited online
Interventions Internet Mindfulness Meditation Intervention (IMMI) iMINDr application guided meditation workbook
Duration Six-week intervention period; participants took 9.9 ± 3.5 weeks to complete the course
Topics Depression Meditation
Key points The Internet Mindfulness Meditation Intervention plus iMINDr app was associated with clinically and statistically significant improvements in depression symptoms, well-being, positive and negative affect, sleep quality, and pain intensity among older adults with depressive symptoms. Participants took an average of 9.9 weeks to complete the six-week course, and high attrition was mainly related to motivation and stress.

Abstract

The growing population of older adults with depression is a significant public health concern, and effective treatments are necessary. Mindfulness meditation intervention offers effective treatment for depression, but little research has been conducted on the older population. This study aimed to evaluate if the combination of the Internet Mindfulness Meditation Intervention (IMMI) plus iMINDr application improves well-being in older adults with depressive symptoms. Potential participants were recruited online. IMMI included a one-hour online session once a week, a daily 30-minute home practice of guided meditation using the iMINDr app, and a workbook. Measures were collected online before and after the six-week intervention period. Online session adherence was tracked. Thirty-eight participants completed all study requirements and are included in the analysis. Participants showed clinically and statistically significant improvements in depression symptoms, well-being, positive and negative affect, sleep quality, and pain intensity. Participants took 9.9 ± 3.5 weeks to complete the course. High attrition rates mainly were related to participants' motivation to complete the course and stress levels. There were no significant demographic differences between participants and depression symptoms. Potential applications and limitations are discussed. Internet Mindfulness Meditation Intervention (IMMI) was effective in treating depression symptoms in older adults.

Comparable studies

Other non-randomized and open-label trials on depression, most cited first.

Study Year Design Participants
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Patients with moderate-to-severe, unipolar, treatment-resistant major depression 2016 Open-label feasibility trial n = 12
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Patients with severe, unipolar, treatment-resistant major depression 2017 Open-label trial n = 20
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17

Citations in the library

Explore topics